Le Lézard
Classified in: Health
Subjects: AWD, TRI, FVT

Brain Research Foundation To Honor Distinguished Service At Discovery Dinner


CHICAGO, Oct. 10, 2017 /PRNewswire/ -- Brain Research Foundation (BRF) will bestow its 2017 Frederic A. Gibbs award to a Chicago couple dedicated to the support and growth of innovative neuroscience research, and a financial company whose philanthropic outreach has made it part of Chicago's cultural mosaic.

John Mabie, founder and chairman of Mid-Continental Capital, and his wife Martha will present the award for philanthropic leadership to Hope and Tom Reynolds for their distinguished commitment to BRF. Mr. Reynolds is a long-serving BRF trustee and a partner at the law firm Winston & Strawn. 

CIBC vice chairman, U.S. Region Norman R. Bobins will present the award for community service to Mesirow Financial, an independent and employee-owned investment, risk-management and advisory services firm headquartered in Chicago. The Discovery Dinner will be held Thursday, October 12 in Chicago.

"The contribution of this year's honorees illustrates the unique role that civic and philanthropic leaders can have in positively impacting important scientific research and initiatives that move our understanding of the brain forward," stated Dr. Terre A. Constantine, BRF Executive Director and CEO. "We are tremendously thankful for our community of dedicated, selfless and generous supporters like Hope and Tom and Mesirow Financial who fuel our work to advance innovative neuroscience research. And we thank BRF board members Norm Bobins and John Mabie for their continued participation in the Foundation and specifically in this year's awards."

The 2017 Brain Research Foundation Annual Gala is chaired by board trustee Richard Chaifetz and board trustee and Chair Peter Pond.

The Discovery Dinner is a major fundraiser for the Foundation and 100 percent of the proceeds go into basic neuroscience research that will impact our understanding and treatment of ALS, Alzheimer's, autism and virtually all neurological diseases and disorders.

About the Brain Research Foundation
Brain Research Foundation supports neuroscience research that leads to advanced understanding of brain function in children and adults. This Foundation is committed to advance discoveries that will lead to novel treatments and prevention of all neurological diseases.  

We deliver this commitment through both research grant programs, which provide initial funding for innovative research projects, as well as educational programs for researchers and the general public. 

Contact:
Deborah Schneider
312-280-8702
[email protected]

 

SOURCE The Brain Research Foundation


These press releases may also interest you

at 12:45
Sogolytics Study Examines Patient Experience Gaps in Telehealth Adoption
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Announces Acquisition of Tricord, Inc.
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, Innovative Treatment Provider for Severe Mental Illness, Announces Closing of Oversubscribed $15 Million Series A Funding Round
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios Secures FDA Breakthrough Device Designation for JuxtaFlow® RAD, Showcases Pioneering Data at Society of Cardiovascular Anesthesiologists Annual Meeting
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine Achieves Highest Accreditation Status from AOA Commission on Osteopathic College Accreditation
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma to Present at LSX World Congress 2024
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

More news about Health...


News published on and distributed by: